Efficacy and safety of exenatide once‐weekly vs exenatide twice‐daily in Asian patients with type 2 diabetes mellitus

AIMS/INTRODUCTION: To compare safety and efficacy of the extended‐release formulation exenatide once weekly (EQW) vs exenatide twice daily (EBID) for 26 weeks in type 2 diabetes patients from China, India, Japan, South Korea and Taiwan. MATERIALS AND METHODS: A randomized, comparator‐controlled, ope...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Linong, Onishi, Yukiko, Ahn, Chul Woo, Agarwal, Pankaj, Chou, Chien‐Wen, Haber, Harry, Guerrettaz, Kelly, Boardman, Marilyn K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley-Blackwell 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019288/
https://www.ncbi.nlm.nih.gov/pubmed/24843631
http://dx.doi.org/10.1111/j.2040-1124.2012.00238.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019288/
https://www.ncbi.nlm.nih.gov/pubmed/24843631
http://dx.doi.org/10.1111/j.2040-1124.2012.00238.x

Ejemplares similares